John Lee is a Nephrology physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
424 E 70th St
New York, NY 100215326
Telephone
646-962-2606Provider last certified this registry record 10 Jul 2023.
Clinical trials
- Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery
Sponsor: Unity Health Toronto
- Indocyanine Green for Central Nervous System Tumors
Sponsor: Abramson Cancer Center at Penn Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CALLIDITAS THERAPEUTICS US INC.Program year20242 payments
- GENZYME CORPORATIONProgram year20241 payment
- GENZYME CORPORATIONProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.4%Calcium channel blocker15.6%Nifedipine Er57%Amlodipine Besylate43%Part D≥44 patientsBeta blocker9.4%Carvedilol42%Metoprolol Succinate27%Labetalol Hcl25%Metoprolol Tartrate7%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
17.1%Corticosteroid4.9%Prednisone100%Part D≥25 patientsProton pump inhibitor4.7%Pantoprazole Sodium62%Omeprazole38%Part D≥19 patients+ 6 more classes in this area
Anti-infectives
9.9%Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor4.3%Valganciclovir Hcl100%Part D≥33 patientsFluoroquinolone Antibacterial1.5%Levofloxacin100%Part D≥20 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 1985–2025 per NIH RePORTER. The latest:
- Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients
Weill Medical Coll of Cornell Univ
FY2025$792,245R01AI184528 - Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities
Weill Medical Coll of Cornell Univ
FY2025$604,993R01DK139249 - Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients
Weill Medical Coll of Cornell Univ
FY2024$796,319R01AI184528
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”